First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion

Stock Information for Bone Biologics Corp

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Bone Biologics Corp

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
Bone Biologics Executives to be Interviewed in a "CEO Chat" by Zacks Small-Cap Research Analyst on June 20th
Bone Biologics Announces Closing of $2.0 Million Public Offering
Bone Biologics Announces Pricing of $2.0 Million Public Offering
Bone Biologics Reports Progress With NB1 Clinical Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.